Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration

被引：0
|
作者：
Bommakanti, Nikhil
Young, Benjamin K.
Sisk, Robert A.
Berrocal, Audina M.
Duncan, Jacque L.
Bakall, Benjamin
Mathias, Marc T.
Ahmed, Ishrat
Chorfi, Sarah
Comander, Jason
Nagiel, Aaron
Besirli, Cagri G.
机构：
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 47 条
  • [31] ECONOMIC MODELLING OF GENE THERAPIES BASED ON THE COMPARISON OF TWO INDEPENDENT MODELS ASSESSING VORETIGENE NEPARVOVEC FOR RPE65-MEDIATED INHERITED RETINAL DYSTROPHY
    Janik, J.
    Paterak, E.
    Pochopien, M.
    Aballea, S.
    Toumi, M.
    VALUE IN HEALTH, 2022, 25 (07) : S351 - S351
  • [32] Early post-approval results of gene therapy for RPE65-mediated retinal dystrophy with Luxturna (voretigene neparvovec) at Massachusetts Eye and Ear
    Rudnick, Noam
    Terrell, David
    Weigel-DiFranco, Carol
    Comander, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [33] Five-Year Post-Injection Results of the Phase 3 Trial of Voretigene Neparvovec-rzyl in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease
    Bennett, Jean
    Russell, Stephen R.
    High, Katherine A.
    Drack, Arlene V.
    Yu, Zi-Fan
    Chung, Daniel C.
    Reape, Kathy
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [34] Inflammation after Voretigene Neparvovec Administration in Patients with RPE65-Related Retinal Dystrophy
    Kessel, Line
    Christensen, Ulrik Correll
    Klemp, Kristian
    OPHTHALMOLOGY, 2022, 129 (11) : 1287 - 1293
  • [35] Phase 3 Efficacy and Safety Study of Voretigene Neparvovec (AAV2-hRPE65v2) in Subjects with RPE65-Mediated Inherited Retinal Dystrophy
    Leroy, Bart Peter
    Maguire, Albert M.
    Russell, Stephen R.
    Yu, Zi-Fan
    Wellman, Jennifer
    Bennett, Jean
    High, Katherine A.
    OPHTHALMOLOGICA, 2016, 236 : 2 - 2
  • [36] Improved Rod Sensitivity as Assessed by Two-Color Dark-Adapted Perimetry in Patients With RPE65-Related Retinopathy Treated With Voretigene Neparvovec-rzyl
    Ku, Cristy A.
    Igelman, Austin D.
    Huang, Samuel J.
    Vasconcelos, Huber
    da Palma, Mariana Matioli
    Bailey, Steven T.
    Lauer, Andreas K.
    Weleber, Richard G.
    Yang, Paul
    Pennesi, Mark E.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2023, 12 (04):
  • [37] Correlation of multi-luminance mobility testing with visual function tests in a phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease
    Chung, Daniel C.
    Russell, Stephen R.
    Bennett, Jean
    Maguire, Albert M.
    Wellman, Jennifer A.
    Yu, Zi-Fan
    Tillman, Amy
    High, Katherine A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] COST-EFFECTIVENESS ANALYSIS OF VORETIGENE NEPARVOVEC VERSUS BEST SUPPORTIVE CARE IN PATIENTS WITH RPE65-MEDIATED INHERITED RETINAL DYSTROPHY: A FRENCH HEALTHCARE SYSTEM PERSPECTIVE
    Cariou, C.
    Baba, J.
    Gherardi, A.
    Roze, S.
    Viriato, D.
    VALUE IN HEALTH, 2019, 22 : S405 - S405
  • [39] Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
    Francesco Testa
    Paolo Melillo
    Valentina Di Iorio
    Claudio Iovino
    Francesco Farinaro
    Marianthi Karali
    Sandro Banfi
    Settimio Rossi
    Michele Della Corte
    Francesca Simonelli
    Scientific Reports, 12
  • [40] Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
    Testa, Francesco
    Melillo, Paolo
    Di Iorio, Valentina
    Iovino, Claudio
    Farinaro, Francesco
    Karali, Marianthi
    Banfi, Sandro
    Rossi, Settimio
    Della Corte, Michele
    Simonelli, Francesca
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345